...
首页> 外文期刊>Pancreas >Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms.
【24h】

Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms.

机译:胰导管腺癌长期随访患者合并分支导管导管内乳头状黏液性肿瘤。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Although branch duct intraductal papillary mucinous neoplasms (BD-IPMNs) are slow-growing tumors with a favorable prognosis, the synchronous occurrence of pancreatic ductal adenocarcinomas (PDAs) in patients with BD-IPMNs has been reported. This study was aimed to elucidate the development of PDAs in long-term follow-up patients with BD-IPMNs. METHODS: We investigated 89 BD-IPMN patients who had no mural nodules and followed them up conservatively at least 2 years (median follow-up, 64 months; range, 25-158 months). All subjects underwent examinations by imaging modalities including endoscopic retrograde pancreatography. We calculated the standardized incidence ratio (SIR) from the vital statistics compiled by the Ministry of Health, Labor, and Welfare of Japan. RESULTS: Among the 89 patients, 4 cases of PDAs distant from BD-IPMN were observed in 552 patient-years of follow-up (7.2 per 1000 patient-years). The expected number was 0.25, and the SIR of PDAs was 15.8 (95% confidence interval [CI], 4.3-40.4; P = 0.00014). Subgroup analyses showed that the incidence of PDAs was significantly increased in patients 70 years or older (SIR 16.7; 95% CI, 3.4-48.7; P = 0.0008) and in women (SIR 22.5; 95% CI, 2.7-81.1; P = 0.0037). CONCLUSIONS: Patients with BD-IPMNs are at a high risk for PDAs. During the follow-up, careful examination is required to detect the development of PDAs in patients with BD-IPMNs.
机译:目的:尽管分支导管导管内乳头状黏液性肿瘤(BD-IPMNs)是生长缓慢的肿瘤,预后良好,但已有报道称BD-IPMNs患者同时发生胰腺导管腺癌(PDAs)。这项研究旨在阐明BD-IPMNs的长期随访患者中PDA的发展。方法:我们调查了89例没有壁结节的BD-IPMN患者,并保守随访了至少2年(中位随访时间为64个月;范围为25-158个月)。所有受试者均接受包括内窥镜逆行胰腺造影在内的影像学检查。我们根据日本厚生劳动省编制的生命统计数据计算了标准化发病率(SIR)。结果:在89例患者中,有552例患者-年的随访观察到4例远离BD-IPMN的PDA(每1000例患者-7.2例)。预期数字为0.25,PDA的SIR为15.8(95%置信区间[CI],4.3-40.4; P = 0.00014)。亚组分析显示,在70岁或以上的患者(SIR 16.7; 95%CI,3.4-48.7; P = 0.0008)和女性(SIR 22.5; 95%CI,2.7-81.1; P = 0.0037)。结论BD-IPMNs患者的PDA风险很高。在随访期间,需要仔细检查以检测BD-IPMN患者的PDA的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号